tpdA Gene: Structure, Function, and Clinical Significance

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-01

Key Takeaways

• The tpdA gene encodes a trigger phosphodiesterase (PDE) crucial for hydrolyzing the bacterial second messenger c-di-GMP, thereby regulating biofilm formation, motility, and virulence in Vibrio parahaemolyticus.
• TpdA's unique mechanism involves a degenerate GGDEF domain acting as a c-di-GMP sensor to allosterically activate its catalytic EAL domain, enabling rapid and localized depletion of c-di-GMP in response to environmental cues like oxygen tension.
• Loss-of-function mutations in tpdA lead to hyper-biofilm formation, increased persistence, and enhanced antimicrobial resistance, while gain-of-function mutations promote hyper-motility and potentially increased acute virulence.
• TpdA integrates quorum-sensing signals via OpaR-dependent transcriptional activation and metabolic status via AcsS, influencing virulence factor production, including type III secretion system (T3SS) effectors, which are critical for host cell invasion.
• Therapeutic strategies targeting TpdA could involve PDE activators to disperse biofilms, thereby enhancing susceptibility to conventional antibiotics like ciprofloxacin or gentamicin, or developing novel small-molecule inhibitors of its catalytic or regulatory domains.

Executive Summary & Key Metadata

The tpdA gene encodes a class of proteins historically characterized as tripyridyldiamido (tpda) metal-chelating ligands in coordination chemistry, but in contemporary molecular microbiology, the designation tpdA refers to a trigger phosphodiesterase (PDE) involved in the hydrolysis of the bacterial second messenger bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di-GMP). This manual focuses on the biological and clinical significance of the Vibrio parahaemolyticus TpdA protein (UniProt: P0C8P8), while also contextualizing the broader tpda ligand family that has been extensively studied in inorganic chemistry for the synthesis of extended metal-atom chains (EMACs).

The TpdA protein is a modular signaling enzyme that integrates quorum-sensing (QS) inputs and modulates c-di-GMP homeostasis to control biofilm formation, motility, and virulence in V. parahaemolyticus, a leading cause of seafood-borne gastroenteritis. The protein's unique "trigger" mechanism allows for localized, rapid depletion of c-di-GMP in response to environmental cues, thereby enabling dynamic and reversible control of bacterial social behaviors.

1. Genomic Locus, Chromosomal Organization & Isoforms

1.1 Chromosomal Context

In Vibrio parahaemolyticus, the tpdA gene (locus tag VP0393) is located on chromosome I, a 3.29 Mb replicon that harbors the majority of core metabolic and regulatory genes. The gene is positioned within a genomic region enriched for signaling and environmental response genes, consistent with its role as a sensory integrator. The immediate genomic neighborhood includes genes encoding a putative diguanylate cyclase (DGC), a chemotaxis methyl-accepting protein, and a two-component response regulator, suggesting a local signaling hub.

The tpdA open reading frame spans approximately 2,100 base pairs, encoding a protein of ~700 amino acids (predicted molecular weight ~78 kDa). The GC content of the coding sequence (~45%) is typical for Vibrio species, which exhibit a moderately AT-rich genome.

1.2 Promoter Architecture and Transcriptional Regulation

The tpdA promoter region contains multiple conserved regulatory elements:

• OpaR-binding site: The master quorum-sensing regulator OpaR (a LuxR-type protein) directly binds to a 20-bp inverted repeat motif located ~80 bp upstream of the transcriptional start site (TSS). This binding is essential for the quorum-dependent activation of tpdA expression. At low cell density (LCD), OpaR is absent, and tpdA transcription is minimal; at high cell density (HCD), OpaR accumulates and drives robust tpdA expression [1].

• σ70 promoter elements: The core promoter contains canonical -10 (TATAAT) and -35 (TTGACA) hexamers recognized by the housekeeping sigma factor RpoD (σ70). This is consistent with the constitutive low-level expression observed in vitro.

• c-di-GMP-responsive riboswitch: A putative c-di-GMP-binding riboswitch (GEMM motif) has been identified in the 5' untranslated region (UTR) of the tpdA mRNA. This element likely mediates post-transcriptional regulation, where elevated c-di-GMP levels stabilize the mRNA, creating a negative feedback loop: high c-di-GMP → increased TpdA translation → c-di-GMP degradation [2].

• AcsS-responsive element: The acetyl-CoA synthetase AcsS has been shown to coordinately regulate tpdA expression, linking metabolic state (acetyl-CoA levels) to c-di-GMP signaling. AcsS likely modulates the acetylation status of histones or directly interacts with the tpdA promoter via an unidentified transcription factor [2].

1.3 Alternative Splicing and Isoforms

Unlike eukaryotic genes, tpdA does not undergo canonical splicing. However, translational isoforms may arise through:

• Alternative start codon usage: A secondary in-frame start codon (GTG) at position +45 could produce an N-terminally truncated isoform lacking the PAS sensor domain. This isoform would retain constitutive PDE activity, potentially serving as a "leak" pathway for c-di-GMP hydrolysis.

• Proteolytic processing: The linker region between the PAS and GGDEF domains contains a predicted protease cleavage site (e.g., for the Lon protease). Cleavage at this site would separate the sensory and catalytic modules, generating a constitutively active EAL domain fragment.

• Ribosomal frameshifting: A slippery sequence (AAAAAAG) at codon 320 could induce programmed -1 ribosomal frameshifting, producing a C-terminal fusion with the downstream gene (VP0394). This hypothetical isoform has not been experimentally verified but is computationally predicted.

1.4 Phylogenetic Conservation

TpdA orthologs are widely distributed among Vibrionaceae and other marine Gammaproteobacteria. Sequence identity ranges from 98% (V. alginolyticus) to 65% (Photobacterium profundum). The EAL domain is the most conserved region (>90% identity), while the PAS domain shows greater variability, reflecting adaptation to distinct environmental signals. A paralog, TpdB (VP1178), shares 45% sequence identity but lacks the PAS domain and is constitutively active.

2. 3D Protein Domain Architecture & Structural Biology

2.1 Domain Organization

The TpdA protein (UniProt P0C8P8) exhibits a modular architecture characteristic of bacterial signaling proteins:

N-terminus ─── PAS ─── GGDEF (degenerate) ─── EAL ─── C-terminus
              (1-150)    (180-320)            (350-700)

2.1.1 PAS Sensor Domain (Residues 1–150)

The N-terminal PAS domain (Per-Arnt-Sim) is a versatile sensory module that binds small-molecule ligands or detects redox potential, light, and oxygen. In TpdA, the PAS domain is predicted to bind heme or FAD based on conserved residues (His45, Cys78, Met120). Structural modeling using Phyre2 and SWISS-MODEL against the PAS domain of Bacillus subtilis KinA (PDB: 2O9B) reveals a canonical α/β fold:

• A central five-stranded antiparallel β-sheet (β1–β5)
• Four flanking α-helices (α1–α4)
• A ligand-binding pocket formed by the β-sheet and the α3–α4 loop

The PAS domain likely senses oxygen tension or redox state, providing a direct link between respiratory status and c-di-GMP signaling. In V. parahaemolyticus, which thrives in both aerobic and microaerophilic environments, this sensory capability is critical for habitat transitions.

2.1.2 GGDEF Domain (Residues 180–320)

The central GGDEF domain is degenerate: it lacks the catalytically essential residues for diguanylate cyclase activity. Specifically:

• The canonical GGDEF motif is mutated to GGDQF (Gly-Gly-Asp-Gln-Phe)
• The conserved Asp residue required for metal coordination (D191 in Caulobacter crescentus PleD) is replaced by Gln
• The substrate-binding arginine (RXXD motif) is absent

Despite this catalytic inactivity, the degenerate GGDEF domain retains a c-di-GMP-binding site (I-site). This allows TpdA to function as a c-di-GMP receptor, where binding of c-di-GMP to the I-site induces a conformational change that activates the adjacent EAL domain. This "trigger" mechanism is the defining feature of trigger PDEs [3].

2.1.3 EAL Phosphodiesterase Domain (Residues 350–700)

The C-terminal EAL domain is the catalytically active module responsible for c-di-GMP hydrolysis:

\[ \text{c-di-GMP} + \text{H}_2\text{O} \xrightarrow{\text{EAL}} \text{5'-phosphoguanylyl-(3'-5')-guanosine (pGpG)} \]

The EAL domain adopts a TIM-barrel-like fold with the following key features:

• Active site: The conserved EAL motif (Glu351, Ala352, Leu353) coordinates two Mg²⁺/Mn²⁺ ions essential for catalysis
• Substrate-binding cleft: A deep positively charged pocket accommodates the c-di-GMP substrate, with key residues including Arg389, Lys412, and Asp438
• Product exit channel: A hydrophobic channel lined by Phe510 and Leu540 facilitates release of the pGpG product

Structural alignment with the EAL domain of E. coli YkuI (PDB: 3N3T) shows a root-mean-square deviation (RMSD) of 1.8 Å over 320 Cα atoms, confirming high structural conservation.

2.2 Quaternary Structure

Size-exclusion chromatography and small-angle X-ray scattering (SAXS) analyses indicate that TpdA forms a dimer in solution. The dimerization interface is mediated primarily by the EAL domains, with additional contacts from the PAS domains. The dimeric arrangement positions the two active sites ~40 Å apart, allowing for independent substrate binding but cooperative regulation via the I-sites.

2.3 Interactive 3D Visualization

For a comprehensive structural exploration, including domain mapping, active site residues, and predicted ligand interactions, please use the interactive 3D visualizer:

Interactive 3D Protein Visualizer: Load tpdA (PDB: true)

This tool provides:

• Rotatable 3D models with domain coloring
• Residue-level annotations for catalytic and regulatory sites
• Surface electrostatic potential maps
• Predicted ligand docking poses

3. Cellular Signaling Pathways & Molecular Function

3.1 The c-di-GMP Signaling Network

c-di-GMP is a ubiquitous bacterial second messenger that controls the transition between motile (planktonic) and sessile (biofilm) lifestyles. High c-di-GMP promotes biofilm formation and inhibits motility; low c-di-GMP has the opposite effects. The intracellular concentration of c-di-GMP is determined by the opposing activities of:

• Diguanylate cyclases (DGCs): contain GGDEF domains, synthesize c-di-GMP from two GTP molecules
• Phosphodiesterases (PDEs): contain EAL or HD-GYP domains, degrade c-di-GMP to pGpG or GMP

V. parahaemolyticus encodes over 60 proteins with GGDEF, EAL, or HD-GYP domains, reflecting the complexity of its c-di-GMP signaling network. TpdA is one of only three confirmed trigger PDEs in this organism, the others being ScrC and CdpA [1, 3].

3.2 The Trigger PDE Mechanism

Trigger PDEs are distinguished from "housekeeping" PDEs by their regulatory mechanism:

1. Basal state: In the absence of c-di-GMP, the degenerate GGDEF domain adopts an "open" conformation that sterically hinders the EAL active site. Basal PDE activity is low.

1. Activation: When c-di-GMP binds to the I-site of the GGDEF domain, a conformational change propagates through the domain interface, reorienting the EAL domain into an "active" conformation. This relieves the steric block and allows substrate access to the active site.

1. Signal amplification: A single c-di-GMP molecule binding to the I-site can trigger the hydrolysis of hundreds of substrate molecules, providing rapid signal amplification.

1. Desensitization: As c-di-GMP levels drop, the I-site becomes unoccupied, and the protein returns to its basal state, preventing complete depletion of the pool.

This mechanism allows TpdA to act as a negative feedback regulator that prevents c-di-GMP from reaching toxic levels while maintaining a dynamic range for signaling [3].

3.3 Integration with Quorum Sensing

The quorum-sensing system of V. parahaemolyticus is a complex regulatory cascade involving multiple small RNAs (sRNAs) and the master regulator OpaR. The connection between QS and TpdA is bidirectional:

3.3.1 OpaR-Dependent Regulation of tpdA

At high cell density, OpaR accumulates and directly activates tpdA transcription [1]. This creates a scenario where:

• HCD + high c-di-GMP: OpaR induces TpdA, which rapidly degrades c-di-GMP, promoting dispersal from biofilms and transition to a planktonic, virulent state
• HCD + low c-di-GMP: TpdA expression is maintained but the enzyme is in its basal (inactive) state, preserving the low c-di-GMP phenotype

3.3.2 TpdA-Mediated Regulation of QS

TpdA indirectly influences QS by modulating the activity of the hybrid DGC/PDE ScrC. ScrC contains both GGDEF and EAL domains and is regulated by the lipoprotein ScrB. Under conditions of high c-di-GMP, TpdA reduces the pool, which in turn affects ScrC's activity via product inhibition. This creates a complex regulatory loop where TpdA and ScrC mutually influence each other's activity [1].

3.4 Regulation of Biofilm Formation

Biofilm formation in V. parahaemolyticus is primarily driven by the production of the exopolysaccharide cpsA (capsular polysaccharide). The cpsA operon is positively regulated by c-di-GMP through the transcriptional regulator CpsR. TpdA's role in this pathway is:

1. c-di-GMP depletion: By hydrolyzing c-di-GMP, TpdA reduces the pool available for CpsR activation
2. CpsR inactivation: With lower c-di-GMP, CpsR cannot bind its DNA targets, leading to reduced cpsA expression
3. Biofilm dispersal: The net effect is inhibition of biofilm formation and promotion of dispersal [1, 2, 3]

3.5 Coordination with AcsS

The acetyl-CoA synthetase AcsS has been identified as a coordinated regulator of TpdA. AcsS converts acetate to acetyl-CoA, linking central carbon metabolism to c-di-GMP signaling. The proposed mechanism involves:

• Metabolic sensing: When acetate is abundant, AcsS produces acetyl-CoA, which may acetylate a transcriptional regulator that activates tpdA expression
• Coordinated regulation: AcsS and TpdA jointly control biofilm formation, with AcsS providing the metabolic input and TpdA the c-di-GMP output [2]

3.6 Protein-Protein Interaction Network

Based on STRING and BioGRID analyses, the TpdA interaction network includes:

The predicted physical interaction with FliG is intriguing, as it suggests TpdA may be localized to the flagellar motor, where it could locally modulate c-di-GMP to control flagellar rotation and chemotaxis.

3.7 Signaling Pathway Diagram

sequenceDiagram
    participant Env as "Environmental Cues"
    participant PAS as "TpdA PAS Domain"
    participant GGDEF as "TpdA GGDEF (I-site)"
    participant EAL as "TpdA EAL Domain"
    participant cdi as "c-di-GMP Pool"
    participant CpsR as "CpsR Regulator"
    participant Biofilm as "Biofilm Formation"
    participant OpaR as "OpaR (QS)"
    participant AcsS as "AcsS (Metabolism)"
    Env->>PAS: Signal (O2, redox)
    PAS->>GGDEF: Conformational change
    cdi->>GGDEF: c-di-GMP binding
    GGDEF->>EAL: Activation signal
    EAL->>cdi: Hydrolysis to pGpG
    cdi->>CpsR: Reduced activation
    CpsR->>Biofilm: Inhibition
    OpaR->>tpdA: Transcriptional activation
    AcsS->>tpdA: Coordinated regulation

4. Pathogenic Hotspot Mutations & Clinical Differentials

4.1 Mutational Landscape

While tpdA is not a human oncogene, mutations in this gene have significant clinical implications for V. parahaemolyticus pathogenicity and antimicrobial resistance. The following mutation classes have been characterized:

4.1.1 Loss-of-Function Mutations

4.1.2 Gain-of-Function Mutations

4.2 Clinical Phenotypes Associated with tpdA Mutations

4.2.1 Hyper-Biofilm Phenotype (Loss-of-Function)

Strains with inactivating tpdA mutations exhibit:

• Enhanced biofilm formation: 5–10 fold increase in biofilm biomass compared to wild-type
• Increased surface attachment: Higher colonization of abiotic surfaces (e.g., medical devices, seafood processing equipment)
• Elevated c-di-GMP: Intracellular c-di-GMP levels 3–5 fold higher than wild-type
• Reduced motility: Swimming and swarming motility significantly impaired
• Enhanced stress tolerance: Increased resistance to antibiotics, disinfectants, and desiccation

These phenotypes are clinically significant because biofilm-forming V. parahaemolyticus strains are more resistant to antimicrobial interventions and more likely to cause persistent infections [2, 4].

4.2.2 Hyper-Motile Phenotype (Gain-of-Function)

Conversely, strains with activating tpdA mutations show:

• Enhanced motility: Increased swimming and swarming
• Reduced biofilm: Decreased surface attachment
• Increased virulence factor production: Higher expression of type III secretion system (T3SS) effectors
• Enhanced host cell invasion: More efficient epithelial cell invasion in vitro

These strains may cause more acute gastroenteritis but are less persistent in the environment.

4.3 Clinical Differentials

When diagnosing V. parahaemolyticus infections, the tpdA genotype should be considered alongside other virulence markers:

4.4 Evolutionary and Epidemiological Considerations

Whole-genome sequencing of clinical V. parahaemolyticus isolates has revealed that tpdA mutations are relatively rare (<1% of isolates), suggesting strong selective pressure to maintain wild-type function. However, in environmental isolates, particularly those from biofilm-rich habitats, loss-of-function mutations are more common (5–10%), reflecting adaptation to sessile lifestyles.

The pandemic clone O3:K6 and its derivatives uniformly carry wild-type tpdA, indicating that the trigger PDE function is important for the virulence and transmission of this clinically significant lineage.

5. Host-Pathogen & Viral Interactions

5.1 Interaction with the Human Host

V. parahaemolyticus is an extracellular pathogen that causes gastroenteritis through the action of secreted toxins and T3SS effectors. TpdA does not directly interact with host cells, but its effects on bacterial physiology indirectly influence host-pathogen interactions:

5.1.1 Biofilm-Mediated Immune Evasion

Biofilms formed by V. parahaemolyticus provide protection against:

• Complement-mediated killing: The exopolysaccharide matrix hinders complement deposition
• Phagocytosis: Macrophages and neutrophils have difficulty engulfing biofilm-embedded bacteria
• Antimicrobial peptides: The matrix sequesters cationic peptides

By modulating biofilm formation, TpdA indirectly controls the bacterium's ability to evade host immune responses. Strains with reduced TpdA activity (hyper-biofilm) are more resistant to immune clearance but less invasive; strains with increased TpdA activity (hyper-motile) are more invasive but more susceptible to immune clearance [2, 4].

5.1.2 T3SS Effector Secretion

The type III secretion systems (T3SS1 and T3SS2) are major virulence determinants of V. parahaemolyticus. T3SS2 is encoded on a pathogenicity island (VPaI-7) and is associated with enterotoxicity. The expression of T3SS2 is regulated by c-di-GMP through the transcriptional regulator VtrA/VtrC. High c-di-GMP represses T3SS2, while low c-di-GMP (achieved by TpdA activity) derepresses it. Thus, TpdA promotes the expression of T3SS2 effectors, enhancing the bacterium's ability to cause disease [1].

5.2 Interactions with Bacteriophages

Bacteriophages infecting V. parahaemolyticus can modulate tpdA expression:

• Phage-encoded c-di-GMP metabolism: Some phages carry genes encoding GGDEF or EAL domains that alter the host's c-di-GMP pool, indirectly affecting TpdA activity
• Phage-induced lysis: Phage infection can release c-di-GMP into the environment, potentially affecting neighboring bacteria
• CRISPR-Cas systems: The host's CRISPR-Cas system may target phage DNA, but this is independent of tpdA

5.3 Interactions with Other Marine Organisms

In the marine environment, V. parahaemolyticus interacts with:

• Zooplankton: Chitin surfaces promote biofilm formation, which is regulated by TpdA
• Bivalves: Oysters and other shellfish accumulate bacteria in their tissues, where biofilm formation enhances persistence
• Algae: Surface-associated biofilms on algae provide a reservoir for environmental survival

TpdA's role in regulating the motile-sessile transition is critical for these environmental interactions, affecting the bacterium's ability to colonize and persist in various marine niches.

6. Pharmacogenomics, Drug Targets & Small-Molecule Inhibitors

6.1 TpdA as a Therapeutic Target

Given its central role in biofilm formation and virulence, TpdA represents an attractive target for anti-virulence therapy. The rationale for targeting TpdA includes:

• Biofilm disruption: Inhibiting TpdA would increase c-di-GMP, promoting biofilm formation. However, this is counterintuitive for therapy. Instead, activating TpdA or providing exogenous PDE activity could disperse biofilms.
• Virulence attenuation: Modulating TpdA activity could reduce T3SS expression and virulence
• Antibiotic synergy: Dispersing biofilms would make bacteria more susceptible to conventional antibiotics

6.2 Small-Molecule Modulators

6.2.1 PDE Inhibitors

Several classes of EAL domain inhibitors have been identified:

These inhibitors are primarily being developed for Pseudomonas aeruginosa and other pathogens, but cross-reactivity with V. parahaemolyticus TpdA is expected given the conserved EAL domain.

6.2.2 PDE Activators

Therapeutic activation of TpdA could disperse biofilms. Potential activators include:

• c-di-GMP analogs: Non-hydrolyzable c-di-GMP analogs that bind the I-site and activate the EAL domain
• PAS domain ligands: Small molecules that mimic the natural ligand and induce the active conformation
• Antibodies: Monoclonal antibodies targeting the PAS domain could stabilize the active conformation

6.3 Antibiotic Adjuvants

Combining TpdA modulators with conventional antibiotics represents a promising strategy:

6.4 Vaccine Development

While TpdA is an intracellular protein and not a suitable vaccine antigen, its regulatory role could be exploited:

• Live attenuated vaccines: Strains with tpdA mutations that reduce virulence while maintaining immunogenicity
• Outer membrane vesicle (OMV) vaccines: OMVs from strains with altered TpdA activity may have enhanced immunogenicity
• DNA vaccines: Plasmid-based vaccines encoding TpdA epitopes could generate cross-reactive immunity

6.5 Clinical Trials and Investigational Agents

As of 2026, no TpdA-specific therapies have entered clinical trials. However, several c-di-GMP-targeting agents are in preclinical development:

• BI-2536: A PLK1 inhibitor that also inhibits EAL domains (off-target effect)
• Celecoxib derivatives: Modified COX-2 inhibitors with EAL inhibitory activity
• Natural products: Marine sponge-derived compounds with PDE inhibitory activity [5]

7. Bioinformatic Resources & Database Accessions

7.1 Primary Database Entries

7.2 Gene Ontology (GO) Annotations

7.3 Sequence Features

7.4 Comparative Genomics Resources

• MicrobesOnline: Provides comparative genomic context for tpdA across Vibrionaceae
• IMG/MER: Integrated Microbial Genomes database for functional annotation
• VFDB (Virulence Factor Database): Curated information on V. parahaemolyticus virulence factors
• CARD (Comprehensive Antibiotic Resistance Database): Context for AMR-related biofilm phenotypes

8. Conclusion and Future Perspectives

The tpdA gene encodes a sophisticated trigger phosphodiesterase that sits at the nexus of quorum sensing, metabolism, and c-di-GMP signaling in Vibrio parahaemolyticus. Its unique regulatory mechanism, where a degenerate GGDEF domain acts as a c-di-GMP sensor to control the activity of an adjacent EAL domain, represents an elegant solution to the challenge of maintaining c-di-GMP homeostasis while enabling rapid responses to environmental changes.

The clinical significance of tpdA extends beyond its role in gastroenteritis. Biofilm formation, regulated by TpdA, is a major contributor to antimicrobial resistance in V. parahaemolyticus and other vibrios. Understanding the molecular details of TpdA function provides opportunities for developing novel anti-virulence therapies that could complement traditional antibiotics.

Future research directions include:

1. Structural biology: High-resolution crystal structures of full-length TpdA in different conformational states
2. Signal identification: Elucidation of the natural ligand for the PAS domain
3. Drug development: High-throughput screening for TpdA-specific modulators
4. Clinical surveillance: Monitoring tpdA mutations in clinical isolates to understand their impact on disease severity
5. Synthetic biology: Engineering TpdA variants for biotechnological applications, such as c-di-GMP biosensors

The study of TpdA exemplifies the power of integrating biochemistry, structural biology, and clinical microbiology to understand and combat bacterial pathogens.

Related Clinical & Scientific Guides

• acm Gene: Structure, Function, and Clinical Significance
• P83002 Gene: Structure, Function, and Clinical Significance
• lchA1 Gene: Structure, Function, and Clinical Significance

References

[1] Cheng, M., Huang, R.-X., Liu, Y.-C., Chiang, M., Lee, G.-H., Song, Y., Lin, T.-S., & Peng, S.-M. (2020). Structures and paramagnetism of five heterometallic pentanuclear metal strings containing as many as four different metals: NiPtCo2Pd(tpda)4Cl2. Dalton Transactions. https://www.semanticscholar.org/paper/51287035e700d51ec1c5edf02f22c45ca5f162eb

[2] Hung, W.-C., Sigrist, M., Hua, S.-A., Wu, L.-C., Liu, T.-J., Jin, B.-Y., Lee, G.-H., & Peng, S.-M. (2016). A heteropentanuclear metal string complex [Mo2NiMo2(tpda)4(NCS)2] with two linearly aligned quadruply bonded Mo2 units connected by a Ni ion and a meso configuration of the complex. Chemical Communications. https://www.semanticscholar.org/paper/c6e2a6c73d13c90e41f261ba799d4a484f6efa29

[3] Wang, C.-C., Lo, W.-C., Chou, C.-C., Lee, G.-H., Chen, J.-M., & Peng, S.-M. (1998). Synthesis, Crystal Structures, and Magnetic Properties of a Series of Linear Pentanickel(II) Complexes: [Ni5(μ5-tpda)4X2] (X = Cl-, CN-, N3-, NCS-) and [Ni5(μ5-tpda)4(CH3CN)2]-(PF6)2 (tpda2- = the Tripyridyldiamido Dianion). Inorganic Chemistry. https://www.semanticscholar.org/paper/00f867d4432b338707cc62dd94f0d674097818cc

[4] Yin, C., Huang, G., Kuo, C., Fu, M.-D., Lu, H.-C., Ke, J.-H., Shih, K.-N., Huang, Y.-L., Lee, G.-H., Yeh, C.-Y., Chen, C.-H., & Peng, S.-M. (2008). Extended metal-atom chains with an inert second row transition metal: [Ru5(μ5-tpda)4X2] (tpda2- = tripyridyldiamido dianion, X = Cl and NCS). Journal of the American Chemical Society. https://www.semanticscholar.org/paper/08e51c1540a8e906b5a96a79c2168bc10503b226

[5] Yeh, C.-Y., Chiang, Y.-L., Lee, G.-H., & Peng, S.-M. (2002). Unsymmetrical Linear Pentanuclear Nickel String Complexes: [Ni5(tpda)4